Skip to content
Open access

Structural and biochemical characterization of disease-associated mutations in the human mitochondrial processing peptidase α-subunit.

Oct 2026 · Journal of Structural Biology · Vol 218, pp. 108384 · 0 citations · 32 references
Medicine

TL;DR

This work provides a mechanistic framework for understanding genotype-phenotype relationships in PMPCA-associated disease and demonstrates that PMPCA mutations impair MPP function through diverse mechanisms involving protein stability, dimerization, substrate selectivity, and allosteric conformational dynamics.

Abstract

The mitochondrial processing peptidase (MPP) is an essential heterodimeric protease responsible for cleavage of N-terminal mitochondrial targeting sequences (N-MTSs) from most nuclear-encoded mitochondrial proteins following import into the mitochondrial matrix. Pathogenic variants in the α-subunit of MPP (PMPCA) cause a spectrum of mitochondrial disorders, including spinocerebellar ataxia type 2 (SCAR2), encephalopathy, and severe neurodevelopmental disease; however, the molecular mechanisms underlying these phenotypes remain poorly understood. Here, we combined biochemical and structural approaches to characterize five disease-associated PMPCA variants (S96L, R185W, R268W, A377T, and G515R). Enzymatic analyses revealed variant-specific defects in substrate processing, with most mutations severely impairing cleavage of the rapidly processed substrate malate dehydrogenase 2. In contrast, several variants exhibited only modest impairment in the processing of the slowly cleaved substrate PINK1. Mass photometry demonstrated reduced heterodimerization of all variants, whereas circular dichroism identified varying degrees of structural destabilization, particularly for S96L and G515R. To define the structural basis of these defects, hydrogen-deuterium exchange mass spectrometry was performed on wild type MPP and selected variants. Pathogenic mutations altered substrate-induced conformational changes within previously characterized substrate-recognition elements, including the glycine-rich loop. Furthermore, we identified a previously unrecognized region, termed the INS loop, that exhibited substrate-dependent protection uniquely in the wild type enzyme but was consistently disrupted across pathogenic variants. Together, these findings demonstrate that PMPCA mutations impair MPP function through diverse mechanisms involving protein stability, dimerization, substrate selectivity, and allosteric conformational dynamics. Our work provides a mechanistic framework for understanding genotype-phenotype relationships in PMPCA-associated disease.

Read PDF

Similar papers

Open access Oct 2026

Impaired Mitochondrial Translation and Bioenergetic Dysfunction Associated with the MT-RNR1 m.1014A>G Variant

Pathogenic variants in MT-RNR1 are classically associated with aminoglycoside-induced sensorineural hearing loss through disruption of the mitochondrial 12S rRNA decoding center. Their contribution to pediatric neurological disease remains poorly defined. We identified a novel homoplasmic MT-RNR1 variant, m.1014A>G, in...

Irene Marrone, Blendi Ura, F. Celsi et al. · 0 citations
Open access Oct 2026

Bi-allelic UQCC1 variants impair mitochondrial complex III assembly causing early-onset mitochondrial disease

Mitochondrial disease arises from variants in either the mitochondrial or nuclear genome that impair mitochondrial oxidative phosphorylation. Complex III (ubiquinol:cytochrome c oxidoreductase, CIII2) is a key enzyme of the mitochondrial respiratory chain, catalyzing electron transfer from reduced coenzyme Q10 (ubiquin...

R. W. Taylor, S. Smith, S. Saadi et al. · 0 citations
Open access Sep 2026

Evolutionary analysis of PINK1 reveals key roles of the N- and C-terminal extensions and TOM20 in folding its kinase domain

These findings support a model in which the NTE and CTE act as intramolecular determinants of PINK1 kinase stability and suggest that vertebrate PINK1 has evolved an increased dependence on the mitochondrial import machinery to maintain a functional state.

Tara Shomali, S. Veyron, J. Trempe · 0 citations
Open access Sep 2026

Characterization of Ataxia-linked MFN2 Variants Reveals a Lipid Droplet/Mitochondrial Axis Driving Ferroptosis

Pathogenic variants in the mitochondrial protein Mitofusin 2 have long been recognized to cause the peripheral neuropathy Charcot-Marie-Tooth Type 2A (CMT2A). However, a small subset of MFN2 variants also impact the central nervous system and cause cerebellar ataxia. The reason for this discrepancy and the mechanisms u...

M. Zaman, A. Mohan, C. Chute et al. · 0 citations
Open access Oct 2026

Small molecules rescue pathogenic POLGA aggregation and restore its functions in a mouse model of PEO.

POLGA, the catalytic subunit of the mitochondrial DNA polymerase, is essential for mitochondrial DNA (mtDNA) replication and maintenance. Mutations in POLGA cause progressive external ophthalmoplegia (PEO), but the underlying pathogenic mechanisms remain unclear. Here, we show that the mitochondrial E3 ligase MITOL hyp...

Aftab Mohammed, Tavleen Kaur, Priyanka Panwar et al. · 0 citations
Review Open access Oct 2026

Protein structure–function relationships as the molecular basis of phenotypic diversity in GDAP1-associated Charcot–Marie–Tooth disease

Mutations in the GDAP1 gene, which encodes the ganglioside-induced differentiation-associated protein 1 (GDAP1)—a member of the detoxifying glutathione S-transferase (GST) superfamily—cause Charcot–Marie–Tooth disease (CMT) a genetically heterogeneous group of inherited neuropathies. This mini review correlates the cli...

V. Bunik, A. Emelyanova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.